Kaufman Beth Zelnick serves as Executive at CorMedix Inc., where they oversee executive responsibilities. Since joining the company, Kaufman Beth Zelnick has executed 10 insider transactions totaling $670.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 4, 2026 involved receiving (via award) 36,006 shares valued at $0.
Kaufman Beth Zelnick currently holds 269,108 shares of CorMedix Inc. (CRMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kaufman Beth Zelnick has been a net seller of CRMD stock. They have purchased $0 and sold $670.3K worth of shares.
Kaufman Beth Zelnick's most recent insider trade was on Feb 4, 2026, when they sold 36,006 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.27 |
| Discretionary |
| Jan 23, 2026 | CRMD | $0 | Award | 72,820 | $N/A | Discretionary |
| Jan 2, 2026 | CRMD | $137.8K | Payment | 11,333 | $12.16 | Discretionary |
| Sep 9, 2025 | CRMD | $5.1K | Sale | 400 | $12.82 | Discretionary |
| Sep 9, 2025 | CRMD | $165.0K | Option Exercise | 50,000 | $3.30 | Discretionary |
| Sep 9, 2025 | CRMD | $665.1K | Sale | 49,600 | $13.41 | Discretionary |
| Aug 29, 2025 | CRMD | $0 | Award | 69,686 | $N/A | Discretionary |
| Aug 29, 2025 | CRMD | $131.7K | Payment | 8,880 | $14.83 | Discretionary |
| Dec 12, 2023 | CRMD | $0 | Award | 50,000 | $N/A | Discretionary |